Skip to main content
Clinical Trials/NCT05868954
NCT05868954
Completed
Not Applicable

Implementation of a Mediterranean Diet Program for Overweight or Obese Pregnant Women in a Low-resource Clinical Setting

Wake Forest University Health Sciences1 site in 1 country41 target enrollmentAugust 31, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Weight Gain
Sponsor
Wake Forest University Health Sciences
Enrollment
41
Locations
1
Primary Endpoint
Diet Adherence Assessment Scores Continuous
Status
Completed
Last Updated
4 months ago

Overview

Brief Summary

The purpose of this Pilot randomized clinical Trial is to compare two healthy diet styles during pregnancy. Patients between 8 and 16 weeks of gestation who agree to participate will be randomly assigned (like flipping a coin) to either receive routine healthy diet advice and counseling, or to receive advice and counseling for the Mediterranean style diet. Our current routine healthy diet program follows the recommendations provided by the American College of Obstetricians and Gynecologists (ACOG). It recommends the consumption of grains, fruits, vegetables, protein foods, and dairy foods during pregnancy. The Mediterranean diet (MedDiet) is a well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with olive oil as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally. Throughout their pregnancy, participants will receive free food and be assessed to determine adherence to the diet and receive counseling to reinforce diet recommendations.

Detailed Description

The Mediterranean diet (MedDiet) is a well-known healthy diet that consists of a large amount of plant-based foods such as fruits, vegetables, beans, and nuts with extra virgin olive oil (EVOO) as the principal source of fat. Dairy, fish, and poultry are consumed in moderation and red meat only eaten occasionally. A growing body of evidence demonstrates that outside of pregnancy, the MedDiet is associated with a reduction of cardiovascular disease, diabetes, metabolic syndrome, and certain cancers. However, the potential clinical benefits of MedDiet in pregnancy are understudied with most data originating from clinical trials in Europe. Proper nutrition during pregnancy has multiple health benefits. A mother eating a healthy diet has a higher probability of meeting the demands required for a normal fetal development. In addition, she is more likely to achieve the recommended gestational weight gain thereby reducing the risk of pregnancy-related complications. Finally, a healthy diet is associated with a reduction of chronic conditions such as cardiovascular disease and diabetes later in life for both the mother and the infant.

Registry
clinicaltrials.gov
Start Date
August 31, 2023
End Date
July 10, 2025
Last Updated
4 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Viable singleton pregnancy in the first trimester (6 0/7- 16 6/7 weeks); includes twins reduced to singleton spontaneously or vanishing twin syndrome
  • BMI ≥ 25.0 kg/m2; calculated by dividing maternal weight in kilograms by height in meters squared using a calibrated scale and standard metric measure
  • Confirmed intrauterine pregnancy by ultrasound exam (6-16 weeks)
  • Age 18 years or older
  • Primary language of English or Spanish

Exclusion Criteria

  • BMI \< 25.0 kg/m2
  • Known pre-pregnancy diabetes
  • Hemoglobin glycosylated (A1C) \> 5.7% at first prenatal visit
  • Pre-pregnancy hypertensive disease
  • Non-viable pregnancy
  • Known allergies to an essential component(s) of MedDiet
  • Inability to read or write in primary language
  • Mental incapacity to make medical decisions

Outcomes

Primary Outcomes

Diet Adherence Assessment Scores Continuous

Time Frame: week 38

The Routine Healthy Diet Assessment Questionnaire consists of 15 items. Each item is scored as 1 for adherence and 0 for non-adherence, with some items having trimester-specific scoring. The total score is the sum of all items, ranging from 0 (no adherence) to 15 (full adherence). Higher scores indicate better adherence to the routine healthy diet .The MedDiet Assessment Questionnaire consists of 17 items. Each item is scored as 1 for adherence and 0 for non-adherence. The total score is the sum of all items, ranging from 0 (no adherence) to 17 (full adherence). Higher scores indicate better adherence to the Mediterranean diet.

Secondary Outcomes

  • Gestational Weight Gain (GWG)(week 40)
  • Cardiovascular Parameters - Blood Pressure (BP) Values (Diastolic)(Week 38)
  • Cardiometabolic Biomarkers - Hemoglobin A1C Levels(Week 30)
  • Cardiometabolic Biomarkers - C-reactive Protein (CRP) Levels(Week 30)
  • Cardiometabolic Biomarkers - Triglycerides(Week 30)
  • Cardiometabolic Biomarkers - Glucose Level(Week 30)
  • Cardiovascular Parameters - Blood Pressure (BP) Values (Systolic)(Week 38)

Study Sites (1)

Loading locations...

Similar Trials